After the acquisition of endometrial ablation innovator Novacept in 2004, a team of women’s health veterans couldn’t stop envisioning a better, non-hormonal solution for heavy periods. Then, one night in 2008, they found themselves with a paper napkin, a pen, and their growing passion to end AUB.

In the prime of their lives, with significant personal and professional responsibilities, 1 in 3 women shoulder the additional burden of pain, heavy bleeding, fatigue and depression–just some of the symptoms associated with AUB1.

One-third of outpatient visits to the gynecologist are for AUB, and AUB accounts for more than 70% of all gynecologic consults in the perimenopausal and post-menopausal years2. This common condition often results in a hysterectomy due to benign causes if not treated.

We are in continuous pursuit of excellence: in engineering, in customer support, and out in the field where our team serves as an extension of yours. Meet some of the people who bring years of experience in women’s healthcare to work each day, but it’s their passion for ending AUB that drives Minerva forward.